1240036
1226395
1226695
1226747
1226694
Clinical research site shines in Khayelitsha
Working on some of the most important breakthroughs in TB diagnostics globally, and testing HIV and TB vaccines, is a vital part of the pioneering work being done at the Khayelitsha-based Wellcome Centre for Infectious Diseases Research in Africa...
Image of scientist holding up a Petri dish
Supporting Excellence
The Wellcome Centre for Infectious Diseases Research in Africa fosters investigator-led approaches via the overarching scientific objective of combatting infection, especially HIV-1 and tuberculosis, through clinical and laboratory research.
Macrophages infected with M. tuberculosis; image by Dr Suraj Parihar
Basic Science
Our Basic Science Platform provides the laboratory infrastructure and technical support to ensure the safe handling of infectious material.
Subgraph of the ANIMA network for dataset HIVsetB
Biomedical Data Integration
We work with multidimensional clinical and scientific data at the molecular, cellular, clinical and population levels.
Image of a researcher and study participant reading an informed consent document
Clinical Research
CIDRI-Africa supports clinical studies in the community at our facility at Site B in Khayelitsha.

News

Friday, 23 August 2019
Clinical research site shines in Khayelitsha

Working on some of the most important breakthroughs in tuberculosis (TB) diagnostics globally, and testing HIV and TB vaccines, is a vital part of the pioneering work being done at the Khayelitsha-based Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa).

Publication Date:
Fri, 02 Aug 2019 - 08:00
Diagram of a CD4+ T cell with CD153 molecule
Understanding the role of the cell surface molecule CD153 in TB protection

Catherine Riou will expand her programme of research with support from the National Institutes of Health (US).

Publication Date:
Thu, 01 Aug 2019 - 11:45
Person wearing gloves and labelling tubes in a laboratory
Why do HIV-positive inpatients with TB die?

People living with HIV who are hospitalized at the time tuberculosis is diagnosed are at high risk of death, even after starting antituberculosis treatment. Charlotte Schutz and members of the CIDRI-Africa team studied a group of patients to find out why.

Publication Date:
Mon, 08 Jul 2019 - 08:15
Head-and-shoulders photo of Prof. Graeme Meintjes
Disseminated HIV-associated tuberculosis is deadly: can treatment for this condition be improved?

CIDRI-Africa PI Prof. Graeme Meintjes has been awarded a Wellcome Trust Senior Research Fellowship to evaluate strategies for improving treatment of this condition.

Publication Date:
Thu, 20 Jun 2019 - 09:15

Pages

TOP